Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Enphase Energy Inc. Stock Falls 4.5%, Underperforms Peers

Enphase Energy Inc. Stock Falls 4.5%, Underperforms Peers

Dow JonesDow Jones2026/08/17 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Enphase Energy Inc. slipped 4.5% to $38.65 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,745.06 and Dow Jones Industrial Average falling 0.5% to 53,459.78.

This was the stock's second consecutive day of losses.

Enphase Energy Inc. closed 47.6% below its 52-week high of $73.74, which the company reached on May 29th.

The stock underperformed when compared to some of its peers, as Eaton Corp. PLC rose 0.9% to $455.40, TE Connectivity PLC rose 0.5% to $217.38, and Amphenol Corp. Cl A rose 2.25% to $170.87.

Trading volume totaled 3.5 million, compared to the 50-day average of 5.7 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 17, 2026 16:34 ET (20:34 GMT)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

siRNA rising star ADARx (ADRX.US) launches $350 millions IPO, AbbVie subscribes to 4.9% of shares with a maximum investment of $100 millions

ADARx plans to raise $350 millions and list on Nasdaq. AbbVie will invest up to $100 millions to acquire a 4.9% stake, with a median valuation of $1.8 billions.

智通财经2026/09/22 07:21

Roche (RHHBY.US) weight loss injection shows positive mid-term trial results: average weight loss of 15.5% over 48 weeks, blood sugar levels drop by 2.65%.

The experimental weight-loss injection enicepatide simultaneously lowered blood sugar and body weight in overweight or obese patients with type 2 diabetes during a mid-stage clinical trial.

智通财经2026/09/22 07:11

SPAC company Silicon Valley Acquisition II (SVATU.US) applies for US stock IPO, aiming to raise up to 220 millions USD.

The blank-check company (SPAC) Silicon Valley Acquisition II submitted a filing to the U.S. Securities and Exchange Commission (SEC) on Monday, planning to raise up to 220 millions USD through an initial public offering (IPO).

智通财经2026/09/22 07:11